Antidote Health
7 known investors
Find your way into Antidote Health
Sign up to find every way you can get introduced to Antidote Health
- Your email: who you already know at Antidote Health, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Antidote Health team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Antidote Health provides virtual primary care through board-certified physicians who deliver telehealth services covering preventive care, chronic disease management, urgent care, and specialized support including women's health and pediatric care.
Investors · 7
How we know: BRM Capital's portfolio page · Not right? Tell us
How we know: Daybreak Partners's portfolio page · Not right? Tell us
How we know: Welltech Ventures's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$12M disclosed across 1 of 3 rounds · 2021–2022
- Undisclosed amountSeries AMar 2022Source ↗
- Undisclosed amountseed roundAug 2021Source ↗
- $12MraisedAug 2021 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Antidote Health do?
- Antidote Health provides virtual primary care through board-certified physicians who deliver telehealth services covering preventive care, chronic disease management, urgent care, and specialized support including women's health and pediatric care.
- Who are Antidote Health's investors?
- Antidote Health's investors include BRM Capital, Daybreak Partners, Longevity Venture Partners, Welltech Ventures, Flint Capital, Group 11, iAngels.
- How much funding has Antidote Health raised?
- Antidote Health has disclosed $12M raised across 1 of its 3 known rounds.





